产品简要
公司名称 :
北京义翘神州
产品类型 :
抗体
产品名称 :
SARS-CoV / SARS-CoV-2 Nucleocapsid Antibody, Mouse MAb
目录 :
40143-MM05
规格 :
100微升
价格 :
230美元
克隆性 :
单克隆
宿主 :
小鼠
共轭标签 :
未共轭
克隆名称 :
05
反应物种 :
SARS冠状病毒, 人类, 小鼠
应用 :
免疫印迹, 酶联免疫吸附测定, 免疫组化, 免疫细胞化学
更多信息或购买 :
文章摘录数: 26
出版应用/物种/样本/稀释参考文献
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Hasenkrug K, Feldmann F, Myers L, Santiago M, Guo K, Barrett B, et al. Recovery from Acute SARS-CoV-2 Infection and Development of Anamnestic Immune Responses in T Cell-Depleted Rhesus Macaques. MBio. 2021;:e0150321 pubmed 出版商
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Leventhal S, Clancy C, Erasmus J, Feldmann H, Hawman D. An Intramuscular DNA Vaccine for SARS-CoV-2 Decreases Viral Lung Load but Not Lung Pathology in Syrian Hamsters. Microorganisms. 2021;9: pubmed 出版商
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Liu H, Plancarte M, Ball E, Weiss C, Gonzales Viera O, Holcomb K, et al. Respiratory Tract Explant Infection Dynamics of Influenza A Virus in California Sea Lions, Northern Elephant Seals, and Rhesus Macaques. J Virol. 2021;95:e0040321 pubmed 出版商
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Hodge C, Rosenberg D, Grob P, Wilamowski M, Joachimiak A, Hura G, et al. Rigid monoclonal antibodies improve detection of SARS-CoV-2 nucleocapsid protein. MAbs. 2021;13:1905978 pubmed 出版商
  • 免疫细胞化学; 人类; 1:100
Lamers M, Mykytyn A, Breugem T, Wang Y, Wu D, Riesebosch S, et al. Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptation. elife. 2021;10: pubmed 出版商
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Park B, Kim J, Park S, Kim D, Kim M, Baek K, et al. MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein. Theranostics. 2021;11:3853-3867 pubmed 出版商
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Bouwman K, Tomris I, Turner H, van der Woude R, Shamorkina T, Bosman G, et al. Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins. PLoS Pathog. 2021;17:e1009282 pubmed 出版商
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Cortese M, Lee J, Cerikan B, Neufeldt C, Oorschot V, Köhrer S, et al. Integrative Imaging Reveals SARS-CoV-2-Induced Reshaping of Subcellular Morphologies. Cell Host Microbe. 2020;28:853-866.e5 pubmed 出版商
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
  • 免疫组化; 小鼠; 图 3a
Liang Y, Li H, Li J, Yang Z, Li J, Zheng H, et al. Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an in vivo hACE2 transfection mouse model. Zool Res. 2020;41:621-631 pubmed 出版商
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Torrente Rodríguez R, Lukas H, Tu J, Min J, Yang Y, Xu C, et al. SARS-CoV-2 RapidPlex: A Graphene-Based Multiplexed Telemedicine Platform for Rapid and Low-Cost COVID-19 Diagnosis and Monitoring. Matter. 2020;3:1981-1998 pubmed 出版商
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Golden J, Cline C, Zeng X, Garrison A, Carey B, Mucker E, et al. Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease. JCI Insight. 2020;5: pubmed 出版商
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Ke Z, Oton J, Qu K, Cortese M, Zila V, McKeane L, et al. Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Nature. 2020;588:498-502 pubmed 出版商
  • 免疫细胞化学; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Stanifer M, Kee C, Cortese M, Zumaran C, Triana S, Mukenhirn M, et al. Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells. Cell Rep. 2020;32:107863 pubmed 出版商
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Liu J, Babka A, Kearney B, Radoshitzky S, Kuhn J, Zeng X. Molecular detection of SARS-CoV-2 in formalin-fixed, paraffin-embedded specimens. JCI Insight. 2020;5: pubmed 出版商
  • 酶联免疫吸附测定; SARS冠状病毒
  • 免疫印迹; SARS冠状病毒
Woelfl F, Léger P, Oreshkova N, Pahmeier F, Windhaber S, Koch J, et al. Novel Toscana Virus Reverse Genetics System Establishes NSs as an Antagonist of Type I Interferon Responses. Viruses. 2020;12: pubmed 出版商
Olsen D, Brasen C, Kahns S, Madsen J, Kierkegaard H, Christensen H, et al. Quantifying SARS-CoV-2 nucleocapsid antigen in oropharyngeal swabs using single molecule array technology. Sci Rep. 2021;11:20323 pubmed 出版商
Qian Y, Lei T, Patel P, Lee C, Monaghan Nichols P, Xin H, et al. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin. J Virol. 2021;95:e0139621 pubmed 出版商
Beumer J, Geurts M, Lamers M, Puschhof J, Zhang J, van der Vaart J, et al. A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses. Nat Commun. 2021;12:5498 pubmed 出版商
Berezowska S, Lefort K, Ioannidou K, Ndiaye D, Maison D, Petrovas C, et al. Postmortem Cardiopulmonary Pathology in Patients with COVID-19 Infection: Single-Center Report of 12 Autopsies from Lausanne, Switzerland. Diagnostics (Basel). 2021;11: pubmed 出版商
Hasenkrug K, Feldmann F, Myers L, Santiago M, Guo K, Barrett B, et al. Recovery from acute SARS-CoV-2 infection and development of anamnestic immune responses in T cell-depleted rhesus macaques. bioRxiv. 2021;: pubmed 出版商
Yan H, Jiao H, Liu Q, Zhang Z, Xiong Q, Wang B, et al. ACE2 receptor usage reveals variation in susceptibility to SARS-CoV and SARS-CoV-2 infection among bat species. Nat Ecol Evol. 2021;5:600-608 pubmed 出版商
Qian Y, Lei T, Patel P, Lee C, Monaghan Nichols P, Xin H, et al. Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin. bioRxiv. 2021;: pubmed 出版商
Maccio U, Zinkernagel A, Shambat S, Zeng X, Cathomas G, Ruschitzka F, et al. SARS-CoV-2 leads to a small vessel endotheliitis in the heart. EBioMedicine. 2021;63:103182 pubmed 出版商
Mykytyn A, Breugem T, Riesebosch S, Schipper D, van den Doel P, Rottier R, et al. SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site. elife. 2021;10: pubmed 出版商
Hekman R, Hume A, Goel R, Abo K, Huang J, Blum B, et al. Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2. Mol Cell. 2020;80:1104-1122.e9 pubmed 出版商
Brocato R, Principe L, Kim R, Zeng X, Williams J, Liu Y, et al. Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2-Infected Syrian Hamsters. J Virol. 2020;94: pubmed 出版商
图像
图像 1 :
北京义翘神州 40143-MM05 图像 1
产品信息
提示 :
Online
目录代码 :
40143-MM05
产品名称 :
SARS-CoV / SARS-CoV-2 Nucleocapsid Antibody, Mouse MAb
产品类型 :
抗体
宿主物种 :
小鼠
克隆性 :
单克隆
共轭 :
未共轭
抗体亚型 :
IgG1
规格 :
100微升
标价 :
230美元
产品描述 :
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant SARS-CoV Nucleoprotein / NP (Catalog#40143-V08B; NP_828858.1; Met1-Ala422). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
物种摘要 :
严重急性呼吸综合征
别名 :
NP-CoV
免疫原 :
Recombinant SARS-CoV Nucleoprotein / NP Protein (Catalog#40143-V08B)
特异性 :
SARS-CoV Nucleocapsid Protein
纯度 :
蛋白质A
缓冲液 :
0.2 μm filtered solution in PBS
应用摘要 :
免疫印迹, 酶联免疫吸附测定
储存 :
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
更多信息或购买 :
公司信息
北京义翘神州
北京市北京经济技术开发区科创十街18号院9号楼
Order@Sinobiological.com
http://www.sinobiological.cn
400-890-9989
公司总部: 中国
北京义翘神州科技股份有限公司(Sino Biological Inc.)是一家从事生物试剂研发、生产、销售并提供技术服务的生物科技公司,主要业务有重组蛋白、抗体、基因和培养基等产品,以及重组蛋白、抗体的开发和生物分析检测等服务。

义翘科技为全球的药品研发企业和生命科学研究机构提供高质量的生物试剂产品和高水平的技术服务。义翘科技目前生产和销售的现货产品种类超过4.6万种,能够全面满足客户对于最接近人体天然蛋白结构和性质的重组蛋白需求,并覆盖生命科学研究的多个领域,为分子生物学、细胞生物学、免疫学、发育生物学、干细胞研究等基础科研方向和创新药物研发提供“一站式”生物试剂产品和技术服务。

义翘科技的客户涵盖大学、科研院所、医药研发企业等国内外各类生物研发单位。目前公司已经在美国、欧洲建立了子公司,累计客户数量超过5,000个,品牌声誉不断累积,已成为生物试剂行业国内领先的科技公司之一。